Clinical Pharmacokinetics Research Laboratory, Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, 125 Fogarty Hall, 41 Lower College Road, Kingston, RI, 02881, USA.
Anal Bioanal Chem. 2011 Apr;400(2):423-33. doi: 10.1007/s00216-011-4804-y. Epub 2011 Feb 26.
The aim of the proposed work was to develop and validate a simple and sensitive assay for the analysis of atorvastatin (ATV) acid, ortho- and para-hydroxy-ATV, ATV lactone, and ortho- and para-hydroxy-ATV lactone in human plasma using liquid chromatography-tandem mass spectrometry. All six analytes and corresponding deuterium (d5)-labeled internal standards were extracted from 50 μL of human plasma by protein precipitation. The chromatographic separation of analytes was achieved using a Zorbax-SB Phenyl column (2.1 mm × 100 mm, 3.5 μm). The mobile phase consisted of a gradient mixture of 0.1% v/v glacial acetic acid in 10% v/v methanol in water (solvent A) and 40% v/v methanol in acetonitrile (solvent B). All analytes including ortho- and para-hydroxy metabolites were baseline-separated within 7.0 min using a flow rate of 0.35 mL/min. Mass spectrometry detection was carried out in positive electrospray ionization mode, with multiple-reaction monitoring scan. The calibration curves for all analytes were linear (R(2) ≥ 0.9975, n = 3) over the concentration range of 0.05-100 ng/mL and with lower limit of quantitation of 0.05 ng/mL. Mean extraction recoveries ranged between 88.6-111%. Intra- and inter-run mean percent accuracy were between 85-115% and percent imprecision was ≤ 15%. Stability studies revealed that ATV acid and lactone forms were stable in plasma during bench top (6 h on ice-water slurry), at the end of three successive freeze and thaw cycles and at -80 °C for 3 months. The method was successfully applied in a clinical study to determine concentrations of ATV and its metabolites over 12 h post-dose in patients receiving atorvastatin.
本研究旨在开发并验证一种灵敏、简单的液相色谱-串联质谱法,用于分析人血浆中的阿托伐他汀(ATV)酸、邻位和对位羟基-ATV、ATV 内酯、邻位和对位羟基-ATV 内酯。所有六种分析物和相应的氘(d5)标记内标均通过蛋白沉淀从 50 μL 人血浆中提取。采用 Zorbax-SB Phenyl 柱(2.1mm×100mm,3.5μm)进行色谱分离。流动相由 0.1%(v/v)冰醋酸在 10%(v/v)甲醇-水(溶剂 A)和 40%(v/v)甲醇-乙腈(溶剂 B)中的梯度混合液组成。所有分析物(包括邻位和对位羟基代谢物)均在 7.0min 内实现基线分离,流速为 0.35mL/min。质谱检测采用正电喷雾电离模式,多反应监测扫描。所有分析物的校准曲线均呈线性(R²≥0.9975,n=3),浓度范围为 0.05-100ng/mL,定量下限为 0.05ng/mL。平均提取回收率在 88.6%-111%之间。日内和日间平均准确度在 85%-115%之间,精密度≤15%。稳定性研究表明,阿托伐他汀酸和内酯形式在室温(冰-水浆 6h)、连续 3 次冻融循环结束时以及在-80°C 条件下放置 3 个月时在血浆中均稳定。该方法已成功应用于临床研究,用于测定接受阿托伐他汀治疗的患者给药后 12h 内的阿托伐他汀及其代谢物浓度。